National

The FDA will scrutinize company data on the safety and effectiveness of the drug, molnupiravir, before rendering a decision.

The beachfront land — known as Bruce's Beach in Manhattan Beach, Calif. — is being returned to the descendants of Charles and Willa Bruce 97 years after it was taken.

Small business owners are left trying to strike a balance between staying safe and getting back to being fully open.

Activists say efforts to end a formal holiday in Columbus’ name remain stalled by politicians and organizations focusing on Italian American heritage.

In the U.S., a widespread clinical practice requires patients with alcoholic liver disease to complete a sobriety period before they can get on the waiting list for a liver.

Texas abortion clinics are canceling appointments they had booked during a 48-hour reprieve from the nation’s most restrictive abortion law.

The most restrictive abortion law in the country is back in effect in Texas, after a temporary block was lifted.

As of Oct. 1, some first-class mail has been delivered more slowly. Some say between that and recent price increases, it spells trouble for the agency.

On Thursday, Pfizer and BioNTech formally applied for emergency use of a lower dose for 5- to 11-year-olds. Here’s what to expect:

The Senate has dodged a U.S. debt disaster by approving legislation to lift the federal limit on new borrowing by nearly a half-trillion dollars.

Now the FDA will have to decide if there’s enough evidence that the shots are safe and will work for younger children like they do for teens and adults.

The order Wednesday by U.S. District Judge Robert Pitman freezes for now the strict abortion law known as Senate Bill 8.

Not wanting to lose momentum, government leaders and employers are looking at strengthening and expanding vaccine requirements.

Days before an Oct. 18 deadline to act, the Senate is tangled in a dangerous partisan standoff over a vote that’s needed to allow the federal government to continue borrowing.

J&J said it filed a request with the FDA to authorize boosters for people 18 and older who previously received the company's one-shot vaccine.